Moleculent Raises $20M to Scale Functional Profiling Platform
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Capital for New Therapy
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
Melbourne, Australia & Tarrytown, New York | April 13, 2026 Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic...
Boston, Massachusetts | April 13, 2026 Vivatides Therapeutics has announced the successful completion of a $54 million oversubscribed Series...
ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
CAMBRIDGE, UK, March 31, 2026 Semarion, a University of Cambridge spin-out company, has announced the successful raise of $3.8...
DORTMUND, Germany, March 17, 2026 iDEL Therapeutics announced the successful close of a €9 million seed financing round led...
CAMBRIDGE, UK, March 17, 2026 Mestag Therapeutics has announced a $40 million financing round to advance its first-in-class oncology...
